University of California San Francisco
Give to UCSFUC San Francisco scientists have designed a large-scale screen that efficiently identifies drugs that are potent cancer-killers when combined, but only weakly effective when used alone. Using this
UCSF discovery that may lead to new treatments for people with IPF.
A handful of brain cells deep in the brain may play a surprising role in controlling women’s bone density.
A UCSF surgeon is among a handful nationwide who are pioneering and studying the outcomes of a new approach to breast reconstruction.
UCSF demonstrates that cancer is a clever engineer, capable of constructing entirely new disease-promoting networks out of raw materials readily available in the cell.
Almost half of the nearly 10 million patients with active tuberculosis each year could potentially be cured with significantly shorter treatments than current guidelines recommend.
Nearly all studies of telomere genetics have been performed in adult populations of European or Asian ancestry, meaning that studies aiming to understand how early environmental exposures impact telomere length across different ethnic groups can’t easily assess the role of natural variations in telomere biology.
UCSF has been awarded a five-year, $20 million grant from the U.S. Food and Drug Administration and the National Institutes of Health to study the impacts of new and emerging tobacco products.
Global and local leaders—including Ban Ki-moon, Mary Robinson and Eric Goosby, MD—gathered with community members at ZSFG to discuss universal health care in California and beyond.
UCSF researchers found that 58 percent of women who resided in a nursing home for more than 90 days before breast cancer surgery experienced significant functional decline one year after surgery.
UCSF scientists found a way to screen people’s blood for hundreds of chemicals at once, a method that will improve our ability to better assess chemical exposures in pregnant women.
A pilot clinical trial by CHORI researchers has found that targeted nutrient therapy can improve lung function in obese individuals with asthma, without requiring weight loss
Follow-up imaging for women with non-metastatic breast cancer varies widely across the country, according to a new study led by researchers at UCSF.
Researchers identified a protein that cancer cells use as a shield to protect the PI3K pathway against targeted drugs, and showed that blocking this protein allowed previously ineffective therapies to slow cancer cell growth and shrink tumors.
The journey from discovering and developing effective, precise medications to using them correctly and safely in patients is hardly fast and easy. Nor is it a straight shot. Scientists in the UCSF School of Pharmacy are challenging the status quo every step of the way.
Esteban Burchard, who arrived at UCSF in 1998, marks the 20th year of his asthma project in May. His lab, which he named the UCSF Asthma Collaboratory, has delved deep into the genetic basis of asthma and of drug response in the disease.